Bioinequivalence of Four 100mg Oral Aspirin Formulations in Healthy Volunteers

[1]  J. Vial,et al.  Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin. , 1990, Australian and New Zealand journal of medicine.

[2]  F. Bochner,et al.  The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. , 1990, Thrombosis research.

[3]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[4]  G. FitzGerald,et al.  Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. , 1988, Thrombosis research.

[5]  J. Miners,et al.  Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. , 1986, British journal of clinical pharmacology.

[6]  P. Ho,et al.  The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. , 1985, British Journal of Clinical Pharmacology.

[7]  B. Weksler,et al.  Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. , 1985, Circulation.

[8]  G. FitzGerald,et al.  Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. , 1984, The New England journal of medicine.

[9]  S. Heptinstall,et al.  DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS , 1981, The Lancet.

[10]  C. Stoddard,et al.  Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. , 1981, The New England journal of medicine.

[11]  R. Nelson,et al.  Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. , 1980, The New England journal of medicine.

[12]  P. Majerus,et al.  Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[13]  John G. Wagner,et al.  Fundamentals of Clinical Pharmacokinetics , 1975 .

[14]  R. Menguy,et al.  Evidence for a Sex-linked Difference in Aspirin Metabolism , 1972, Nature.

[15]  G. Levy,et al.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man , 1972, Clinical pharmacology and therapeutics.

[16]  M. Rowland,et al.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution. , 1972, Journal of pharmaceutical sciences.

[17]  F. Bochner,et al.  Determination of plasma aspirin and salicylic acid concentrations after low aspirin doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detection. , 1987, Journal of chromatography.

[18]  F. Bochner,et al.  Measurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assay. , 1980, Therapeutic drug monitoring.

[19]  M. Gibaldi.  Biopharmaceutics and clinical pharmacokinetics , 1977 .